ATE352315T1 - Neospora impstoff - Google Patents

Neospora impstoff

Info

Publication number
ATE352315T1
ATE352315T1 AT98951045T AT98951045T ATE352315T1 AT E352315 T1 ATE352315 T1 AT E352315T1 AT 98951045 T AT98951045 T AT 98951045T AT 98951045 T AT98951045 T AT 98951045T AT E352315 T1 ATE352315 T1 AT E352315T1
Authority
AT
Austria
Prior art keywords
neospora
vaccines
tachyzoites
vaccine
caninum
Prior art date
Application number
AT98951045T
Other languages
English (en)
Inventor
Leszek Choromanski
Karen K Brown
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of ATE352315T1 publication Critical patent/ATE352315T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C12N1/105—Protozoal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/90—Protozoa ; Processes using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98951045T 1997-10-20 1998-10-13 Neospora impstoff ATE352315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95453197A 1997-10-20 1997-10-20

Publications (1)

Publication Number Publication Date
ATE352315T1 true ATE352315T1 (de) 2007-02-15

Family

ID=25495565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98951045T ATE352315T1 (de) 1997-10-20 1998-10-13 Neospora impstoff

Country Status (12)

Country Link
US (2) US20020146436A1 (de)
EP (1) EP1032416B1 (de)
JP (1) JP2001520205A (de)
KR (1) KR20010024245A (de)
AT (1) ATE352315T1 (de)
AU (1) AU745183B2 (de)
BR (1) BR9812976A (de)
CA (1) CA2306642A1 (de)
DE (1) DE69836976T2 (de)
ES (1) ES2281936T3 (de)
NZ (1) NZ504035A (de)
WO (1) WO1999020303A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010024245A (ko) 1997-10-20 2001-03-26 조지 제이. 리코스 네오스포라 백신
EP0953641A3 (de) 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) 2000-07-28 2000-08-24 Insearch Limited Parasites
ES2263317B2 (es) * 2003-12-04 2007-10-01 Universidad Complutense De Madrid Uso del gen ncsag4 para el diagnostico y prevencion de la neosporosis, y como marcador para el analisis de la patogenia.
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) * 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
KR101144994B1 (ko) * 2008-05-06 2012-06-27 대한민국 소 네오스포라병 백신，이의 제조방법 및 이를 이용한 소네오스포라병 예방방법
NZ709547A (en) * 2008-06-27 2017-01-27 Zoetis Services Llc Novel adjuvant compositions
IN2012DN03418A (de) 2009-10-09 2015-10-23 Childrens Medical Center
ES2960032T3 (es) 2015-10-28 2024-02-29 Univ Madrid Complutense Composición de una vacuna de Neospora
US11453854B2 (en) * 2016-10-05 2022-09-27 Zoetis Services Llc Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582798A (en) 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6476192B1 (en) * 1996-04-15 2002-11-05 Nicola C. Lally Recombinant antigens useful for the serodiagnosis of neosporosis
EP0841392B1 (de) * 1996-11-12 2004-07-14 Pfizer Inc. Attenuierter lebender Neospora Impfstoff
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
KR20010024245A (ko) 1997-10-20 2001-03-26 조지 제이. 리코스 네오스포라 백신
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
KR20010024245A (ko) 2001-03-26
DE69836976T2 (de) 2007-11-08
NZ504035A (en) 2002-04-26
EP1032416B1 (de) 2007-01-24
AU745183B2 (en) 2002-03-14
JP2001520205A (ja) 2001-10-30
DE69836976D1 (de) 2007-03-15
AU9693898A (en) 1999-05-10
US20020146436A1 (en) 2002-10-10
CA2306642A1 (en) 1999-04-29
ES2281936T3 (es) 2007-10-01
US7462359B2 (en) 2008-12-09
BR9812976A (pt) 2000-08-08
US20050186227A1 (en) 2005-08-25
WO1999020303A1 (en) 1999-04-29
EP1032416A1 (de) 2000-09-06

Similar Documents

Publication Publication Date Title
PT851927E (pt) Compostos para imunoterapia e diagnostico de tuberculose
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
ATE229978T1 (de) Helicobacter proteine und impstoffe
BR9916857A (pt) 4 heteroaril diarilaminas
EP0958364A4 (de) Immuntherapie und verbesserte impfstoffe
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
DE69434475D1 (de) Impfstoff gegen prostatakrebs
ATE352315T1 (de) Neospora impstoff
EP2172551A3 (de) Verbindungen zur Immuntherapie und Diagnose von Tuberkulose und Verfahren zu deren Verwendung
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
EA199900069A1 (ru) Вакцинная композиция против малярии
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
EP0841392A3 (de) Attenuierter lebender Neospora Impfstoff
EA199900627A1 (ru) Универсальные т-клеточные эпитопы, используемые для получения антималярийных вакцин
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
DE69838324D1 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
GB9810084D0 (en) Proteins
AR027540A1 (es) Utilizacion de la proteina mic3 de toxoplasma gondii o de uno de sus derivados como agente inmunogeno o como antigeno de vacunacion
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
DK1027895T3 (da) Erysipelothrix rhusiopathiae-antigener og vaccinepræparater
MX9401384A (es) Uso de vacunas anti-helminticas en el control de la enfermedad por parasitos asociada con la perdidade la inmunidad natural.
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
WO2002024147A3 (en) Avian pneumovirus vaccine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1032416

Country of ref document: EP

REN Ceased due to non-payment of the annual fee